According to Qiagen 's latest financial reports the company's current EPS (TTM) is $1.54. In 2022 the company made an earnings per share (EPS) of $1.85 a decrease over its 2021 EPS that were of $2.25.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.54 | -16.76% |
2022 | $1.85 | -17.73% |
2021 | $2.25 | 43.89% |
2020 | $1.56 | -955.37% |
2019 | -$0.18 | -121.74% |
2018 | $0.84 | 380.71% |
2017 | $0.17 | -49.8% |
2016 | $0.35 | -38.87% |
2015 | $0.57 | 9.39% |
2014 | $0.52 | 68.72% |
2013 | $0.31 | -45.35% |
2012 | $0.56 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | $15.44 | 902.50% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | $5.36 | 248.02% | ๐บ๐ธ USA |
![]() General Electric GE | -$0.41 | -126.62% | ๐บ๐ธ USA |
![]() Hologic HOLX | $3.02 | 96.08% | ๐บ๐ธ USA |
![]() Bio-Techne TECH | $1.73 | 12.49% | ๐บ๐ธ USA |